newsfilter
← Latest News
PR Newswire·

Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition

Abbott (NYSE: ABT), the global healthcare leader, today announced U.S. Food and Drug Administration (FDA) approval for updates to the CardioMEMS HF...